Eventide Asset Management, LLC Verona Pharma PLC Transaction History
Eventide Asset Management, LLC
- $6.2 Billion
- Q1 2024
A detailed history of Eventide Asset Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,187,520 shares of VRNA stock, worth $26.4 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
2,187,520
Previous 1,377,781
58.77%
Holding current value
$26.4 Million
Previous $27.4 Million
28.5%
% of portfolio
0.57%
Previous 0.46%
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
117Shares Held
60.7MCall Options Held
139KPut Options Held
67.8K-
Nea Management Company, LLC Timonium, MD5.11MShares$61.7 Million5.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.91MShares$47.2 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$45.4 Million1.27% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.61MShares$43.6 Million7.77% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.4MShares$41 Million1.23% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $736M
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...